Cholesterol Self-testing in Patients Post Acute Coronary Syndrome
Recruiting
N/A
Interventional Study
Acute Coronary Syndrome
Prevention
LDL Hyperlipoproteinemia
Therapeutic Adherence
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 200 (estimated)
- Sponsor
- University of Leipzig · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The pharmacological reduction of LDL-C lowers cardiovascular risk and is therefore a priority in cardiovascular secondary prevention. The achievement of LDL-C target levels in Germany, Europe, and worldwide is inadequate, despite a wide array of lipid-lowering medications. Only a small proportion of post-myocardial infarction patients reach their LDL-C target range within a year. There is a signif…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years
* Patients with acute coronary syndrome in the last 6 months and not having reached the LDL target value
* Signed informed consent
Exclusion Criteria:
* Persons unable to understand the study
* Persons unable or unwilling to perform self-measurements
* Persons…
Contacts